Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

22q11 deletion syndrome : parents' and children's experiences of educational and healthcare provision in the UK

Cohen, Wendy and McCartney, Elspeth and Crampin, Lisa (2017) 22q11 deletion syndrome : parents' and children's experiences of educational and healthcare provision in the UK. Journal of Child Health Care. ISSN 1741-2889

[img]
Preview
Text (Cohen-etal-JCHC2016-22q11-deletion-syndrome)
Cohen_etal_JCHC2016_22q11_deletion_syndrome.pdf
Accepted Author Manuscript

Download (407kB)| Preview

    Abstract

    Objective: 22q11DS is a genetic syndrome, prevalence around 1:4000-1:6000 livebirths, with a complex array of associated features, impacting on healthcare and educational support. This study reports the perceptions of families and individuals with 22q11DS in relation to these needs. Design: Individuals and families of those with 22q11DS were approached though two national charities – the Max Appeal and 22Crew. An initial observational survey design was used to gather views via questions probing access to healthcare and educational experiences. Results: 34 responses were received and the data subjected to descriptive analysis. Over half of respondents were diagnosed before the age of 1. 91% reported ongoing difficulties with learning at school, compounded by school attendance being compromised as a result of medical interventions. Individuals reported engaging heavily with educational support and a high number of health professions (mean 9.5; mode 10). Conclusions: Age of diagnosis of 22q11Ds ranged from birth to 9 years. Families had ongoing concerns about aspects of education and healthcare services, and lack of knowledge and awareness of the difficulties faced by individuals with 22q11DS was raised. Healthcare and education providers should be aware of the range of services individuals required on a regular basis so as to provide a more holistic approach to care.